Compare, Analyse Elder Pharma with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ELDER PHARMA   ACTAVIS
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
ACTAVIS
Dec-18
ELDER PHARMA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs38013,754-   
Low Rs1889,226-   
Sales per share (Unadj.) Rs491.23,373.8-  
Earnings per share (Unadj.) Rs-3.2-1,086.7-  
Cash flow per share (Unadj.) Rs14.4355.5-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs376.513,915.5-  
Shares outstanding (eoy) m20.54332.60-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.63.4 17.0%   
Avg P/E ratio x-89.3-10.6 844.2%  
P/CF ratio (eoy) x19.732.3 61.0%  
Price / Book Value ratio x0.80.8 91.4%  
Dividend payout %00-   
Avg Mkt Cap Rs m5,8333,821,601 0.2%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m2,1790-   
Avg. sales/employee Rs ThNM66,398.8-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM-21,387.1-  
INCOME DATA
Net Sales Rs m10,0891,122,140 0.9%  
Other income Rs m25721,459 1.2%   
Total revenues Rs m10,3461,143,599 0.9%   
Gross profit Rs m-79229,406 -2.7%  
Depreciation Rs m361479,690 0.1%   
Interest Rs m2,75664,754 4.3%   
Profit before tax Rs m-3,653-493,580 0.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m3,713125,883 2.9%   
Tax Rs m125-6,255 -2.0%   
Profit after tax Rs m-65-361,442 0.0%  
Gross profit margin %-7.82.6 -299.5%  
Effective tax rate %-3.41.3 -270.3%   
Net profit margin %-0.6-32.2 2.0%  
BALANCE SHEET DATA
Current assets Rs m9,240460,243 2.0%   
Current liabilities Rs m9,998407,146 2.5%   
Net working cap to sales %-7.54.7 -158.7%  
Current ratio x0.91.1 81.8%  
Inventory Days Days4620 236.5%  
Debtors Days Days6066 90.4%  
Net fixed assets Rs m10,124127,020 8.0%   
Share capital Rs m2060-   
"Free" reserves Rs m5,5820-   
Net worth Rs m7,7344,628,303 0.2%   
Long term debt Rs m4,8891,629,793 0.3%   
Total assets Rs m22,8827,235,091 0.3%  
Interest coverage x-0.3-6.6 4.9%   
Debt to equity ratio x0.60.4 179.5%  
Sales to assets ratio x0.40.2 284.3%   
Return on assets %11.8-4.1 -286.8%  
Return on equity %-0.8-7.8 10.8%  
Return on capital %22.3-4.8 -460.9%  
Exports to sales %3.00-   
Imports to sales %0.40-   
Net fx Rs m1810-   
CASH FLOW
From Operations Rs m11,754400,898 2.9%  
From Investments Rs m-561220,241 -0.3%  
From Financial Activity Rs m-6,762-688,062 1.0%  
Net Cashflow Rs m4,432-66,588 -6.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 71.08 Rs / USD

Compare ELDER PHARMA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare ELDER PHARMA With: ALEMBIC PHARMA  UNICHEM LAB  PLETHICO PHARMA  AJANTA PHARMA  DISHMAN PHARMA  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views On News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA 5-YR ANALYSIS

COMPARE ELDER PHARMA WITH

MARKET STATS